JUL 23, 2019 8:40 PM PDT

Maintenance of Shelf-Stable Drugs

WRITTEN BY: Nouran Amin

In a study published in the Proceedings of the National Academy of Sciences, scientists have designed a mathematical model that illustrates how some drugs reduce their stability and shelf-life. These drugs are typically those that utilize monoclonal antibodies for the treatment of certain diseases—such as autoimmunity and cancer.

"Highly concentrated protein solutions can separate into different phases, like a vinaigrette salad dressing separating into layers over time," said Bradley Rogers, graduate student in chemistry at Penn State and first author of the paper. "Phase separation is one of the pathways that makes these drugs unstable and unsuitable for use. The classical method to understand this process involves manipulating the temperature of one sample over time. We used a temperature gradient microfluidics platform to quickly look at many temperatures simultaneously."

A solution rich in antibodies will begin as clear liquid at room temperature and will eventually form cloudy droplets as the solution cools. These droplets will settle with dilute liquid placed on top allowing the samples to appear clear.

"We observed that the rate that a solution separates into two phases has a strange dependence on temperature," said Rogers. "This relationship is much more complicated for concentrated antibody solutions than it is for other systems. We spent a long time trying to make sense of the data, but we eventually developed a model that explains what we are seeing."

To facilitate their studies, researchers used an innovative technique, known as dark-field imaging, to create a range of temperatures across a temperature gradient and to ultimately examine phase transitions.

Penn State: A new study used a temperature gradient to observe how highly concentrated antibody solutions, like those common in some drugs, separate into phases, like an oil and water solution. At colder temperatures, cloudy droplets begin to form in the once clear solution. As the droplets grow and settle to the bottom of the container, the solution separates into two distinct phases. This phase separation can affect a drug’s shelf life and stability. IMAGE CREDIT: PENN STATE

"We observed that the rate that a solution separates into two phases has a strange dependence on temperature," said Rogers. "This relationship is much more complicated for concentrated antibody solutions than it is for other systems. We spent a long time trying to make sense of the data, but we eventually developed a model that explains what we are seeing."

Learn more about drug instability:

The study is critical to advancing drug delivery methods since many drugs today are stored as solids and dissolved in IV solutions. Particularly, pharmaceutical industries are hoping to move towards manufacturing drugs that can be stored as liquids and delivered through an injection.

"If these parameters can help us predict stability and shelf life, we may be able to select better drug candidates," said Rogers. "We may also be able to determine the ideal solution properties for a promising drug candidate to keep it stable."

Source: Science Daily

 

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAR 05, 2021
Drug Discovery & Development
Personalized Treatment for Sickle Cell Disease
MAR 05, 2021
Personalized Treatment for Sickle Cell Disease
Globally, the most prevalent inherited blood disease is sickle cell which affects 70,000 to 100,000 Americans. Despite s ...
APR 02, 2021
Technology
Protein Modeling of SARS-CoV-2 Provides Targets for Vaccine Development
APR 02, 2021
Protein Modeling of SARS-CoV-2 Provides Targets for Vaccine Development
Recent protein modeling of the SARS-CoV-2 spike protein reveals novel areas for vaccine development. The novel SARS-CoV- ...
APR 24, 2021
Drug Discovery & Development
Lithium Treats Intellectual Disabilities in Mice
APR 24, 2021
Lithium Treats Intellectual Disabilities in Mice
Mouse models of Bardet-Biedl Syndrome (BBS) have a challenge with learning as a result of dysfunctional neuronal systems ...
MAY 15, 2021
Drug Discovery & Development
New Weight Loss Drug Converts Energy-Storing Fat into Energy-Burning Fat
MAY 15, 2021
New Weight Loss Drug Converts Energy-Storing Fat into Energy-Burning Fat
According to the World Health Organization (WHO), in 2016, around 2 billion adults around the world were overweight ...
MAY 22, 2021
Drug Discovery & Development
Drug Combo Treats 86% of Patients with Gout
MAY 22, 2021
Drug Combo Treats 86% of Patients with Gout
Researchers at the University of Michigan have found that a combination of two drugs is twice as effective as current tr ...
JUN 09, 2021
Drug Discovery & Development
New Drug Prevents Dementia After Head Injury
JUN 09, 2021
New Drug Prevents Dementia After Head Injury
Researchers led by the University of South Australia have identified a new drug that may be able to help prevent athlete ...
Loading Comments...